For one thing, PRDX1 may prevent oxidative stress-mediated ERα loss through antioxidant function, thereby contributing to maintaining the ER-positive phenotype of breast tumors and improving the prognosis of breast cancer (O’Leary et al., 2014). The gene discussed is PRDX1; the disease is breast carcinoma.